1. Use of Monoclonal Antibodies for the Diagnosis of T-cell Malignancies: Applications and Limitations
- Author
-
Nina Hastrup, Gorm Pallesen, and Elisabeth Ralfikiaer
- Subjects
Cancer Research ,Pathology ,medicine.medical_specialty ,medicine.diagnostic_test ,medicine.drug_class ,T cell ,Hematology ,Biology ,Monoclonal antibody ,Phenotype ,Lymphatic system ,medicine.anatomical_structure ,Oncology ,hemic and lymphatic diseases ,Biopsy ,Immunology ,medicine - Abstract
Biopsy samples from 136 peripheral T-cell lymphomas have been examined and compared with benign inflammatory T-cell infiltrates in an attempt to establish whether immunohistological methods may help to improve the distinction between these conditions. The results confirm and extend previous reports and indicate that the aberrant T-cell phenotypes constitute the single most reliable criterion for the distinction between benign and malignant T-cell infiltrates. These phenotypes are expressed frequently in T-cell malignancies in. lymphoid organs and are also seen in a substantial number of biopsy samples from advanced cutaneous T-cell lymphomas (CTCL). In contrast, early CTCL do not express aberrant T-cell phenotypes and are indistinguishable from benign cutaneous conditions in terms of their immunophenotypic properties. It is concluded that immunophenotypic techniques form a valuable supplement to routine histological methods for the diagnosis of T-cell lymphomas in lymphoid organs. The methods may also help to improve the diagnosis of advanced CTCL, but are of no or only limited help for the recognition of the early stages.
- Published
- 2016